Skip to content

Enhancing Early-Phase Care for Primary Care Patients With Unhealthy Substance Use

Enhancing Early-Phase Care for Primary Care Patients With Unhealthy Substance Use

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01887665
Enrollment
13
Registered
2013-06-27
Start date
2013-08-31
Completion date
2016-03-31
Last updated
2016-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Substance Use Disorders

Keywords

substance use disorders, substance abuse, substance abuse treatment, contingency management

Brief summary

The clinical trial portion of this study tests the hypothesis that contingency management-based incentives for primary care patients with substance use disorders to attend treatment services will increase treatment initiation and engagement. The investigators are investigating whether this approach that has been found effective in specialty treatment settings will work in the primary care context, in conjunction with screening.

Interventions

BEHAVIORALincentives

A structured system of prize-based financial incentives rewards attendance at treatment visits.

Sponsors

National Institute on Drug Abuse (NIDA)
CollaboratorNIH
Brandeis University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Positive self-report alcohol or drug use screen in primary care * Diagnosis of substance use disorder * age 18 or older

Exclusion criteria

* SUD treatment in past 60 days * cognitive impairment

Design outcomes

Primary

MeasureTime frameDescription
Initiation90 daysHad initial outpatient treatment visit following positive screen and confirmatory diagnosis
Engagement90 daysHad two additional outpatient treatment visits after initiating treatment

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026